The estimated Net Worth of Joseph L Farmer is at least $431 Thousand dollars as of 1 August 2018. Joseph Farmer owns over 625 units of AMAG Pharmaceuticals stock worth over $211,975 and over the last 18 years Joseph sold AMAG stock worth over $219,417.
Joseph has made over 9 trades of the AMAG Pharmaceuticals stock since 2007, according to the Form 4 filled with the SEC. Most recently Joseph exercised 625 units of AMAG stock worth $15,625 on 1 August 2018.
The largest trade Joseph's ever made was exercising 12,000 units of AMAG Pharmaceuticals stock on 8 March 2007 worth over $92,760. On average, Joseph trades about 2,228 units every 260 days since 2006. As of 1 August 2018 Joseph still owns at least 8,479 units of AMAG Pharmaceuticals stock.
You can see the complete history of Joseph Farmer stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is C/O ADVANCED MAGNETICS, INC., 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140.
Over the last 18 years, insiders at AMAG Pharmaceuticals have traded over $162,079,471 worth of AMAG Pharmaceuticals stock and bought 3,622,220 units worth $65,172,892 . The most active insiders traders include Capital, Llc Armistice Capi..., Capital Partners Gp, L.L.C...., and Capital Management Lp Camber. On average, AMAG Pharmaceuticals executives and independent directors trade stock every 42 days with the average trade being worth of $2,148,850. The most recent stock trade was executed by Capital Management Lp Camber on 1 October 2020, trading 4,390,000 units of AMAG stock currently worth $59,572,300.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
AMAG Pharmaceuticals executives and other stock owners filed with the SEC include: